StimCardio plans to allocate the capital towards its upcoming multicentre pivotal clinical trial, NeuroPulse 2.

The funding will support a pivotal trial of the company's wrist-worn nerve stimulation device, designed to reduce a-fib ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Predicting how a person’s heart will respond to a new ...